AU Patent

AU2016368289C1 — Methods and compositions for treating a Serpinc1-associated disorder

Assigned to Genzyme Corp · Expires 2023-11-16 · 3y expired

What this patent protects

The invention relates to iRNA,

USPTO Abstract

The invention relates to iRNA,

Drugs covered by this patent

Patent Metadata

Patent number: AU2016368289C1
Jurisdiction: AU
Classification: —
Expires: 2023-11-16
Drug substance claim: No
Drug product claim: No
Assignee: Genzyme Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.